• BridgeBio Pharma average ebitda margin for 2023 was -5215.45%, a 675.89% decline from 2022.
• BridgeBio Pharma average ebitda margin for 2022 was -672.19%, a 22.36% increase from 2021.
• BridgeBio Pharma average ebitda margin for 2021 was -865.75%, a 55.18% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.